Clinical Trial

Magenta Elevate™ First-in-Human Clinical Study in High-Risk PCI Patients

Study acronym: ELEVATE I
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 30, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The Elevate™ First-In-Human (FIH) study is designed to evaluate the initial safety and device functionality of the Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in patients undergoing non-emergent, high-risk percutaneous coronary interventions.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-24; most recent amendment 2025-05-29.
Status change: Recruiting → Active, Not Recruiting 2025-05-29
Status change: Active, Not Recruiting → Recruiting 2025-02-25
Trial Details
NCT Number NCT06099548
Lead Sponsor Magenta Medical Ltd.
Conditions High-Risk Percutaneous Coronary Intervention
Enrollment 20 participants
Start Date 2020-12-17
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-30